A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gefitinib Impurity 16 | CAS 350-30-1 - Request Quote

Picture of Gefitinib Impurity 16

Gefitinib Impurity 16

SZ CAT No:SZ-G018034
CAS No
350-30-1
Mol.F.
C6H3ClFNO2
Mol.Wt.
175.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gefitinib Impurity 16 is chemically 2-Chloro-1-fluoro-4-nitrobenzene. Gefitinib Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 350-30-1

Purchase 350-30-1

Order 350-30-1

Enquire 350-30-1

price of 350-30-1

350-30-1 Supplier

350-30-1 Manufacturer

350-30-1 Exporter

buy high quality Gefitinib Impurity 16

Purchase Gefitinib Impurity 16

Gefitinib Impurity 16 suppliers

Gefitinib Impurity 16 manufacturers

Gefitinib Impurity 16 price

Order Gefitinib Impurity 16

Enquire Gefitinib Impurity 16

Gefitinib Impurity 16 cost

Gefitinib Impurity 16 Supplier

Gefitinib Impurity 16 Distributor

Gefitinib Impurity 16 for Method Validation

Gefitinib Reference Standard

Gefitinib Impurity 16 for ANDA Filing

Gefitinib Impurity 16 for Forced Degradation Studies

Gefitinib Impurity 16 Identification Standards

Gefitinib Impurity 16 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,